BrightInsight accelerates time to market for our customers’ digital health products, including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD) across therapeutic areas.
CSL Behring leveraged the BrightInsight Platform to launch a mobile app for adult patients with rare diseases who are taking Hizentra.
Read
The BrightInsight Platform was selected to accelerate development of one of Sanofi’s Best-In-Class Software as a Medical Device.
Learn More
Insights from top digital health executives on how to speed time to market and lower costs for SaMD solutions.
Read the White Paper
Led by General Catalyst, the Financing will Fuel BrightInsight’s Hypergrowth as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech
Learn More
Watch an on-demand webinar with Paul Upham, Head of Smart Devices at Roche/Genentech, where he discusses how Roche launched a regulated SaMD dosing calculator for treating hemophilia A in Europe.
Watch
Research insights into the biggest digital health opportunities for biopharma in biologics for autoimmune conditions
Read Now
Using a regulated infrastructure alleviates regulatory concerns as you’re developing your product over years and years. You can be confident that from an infrastructure standpoint, you’ll be compliant.
- Bradley Merrill Thompson, Epstein Becker & Green, P.C.